References
- Aagaard L, Rossi JJ. (2007). RNAi therapeutics: Principles, prospects and challenges. Adv Drug Deliv Rev 59:75–86
- Anderson JM, Shive MS. (1997). Biodegradable and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5–24
- Filipowicz W. (2005). RNAi: The nuts and blots of the RISC machine. Cell 122:17–20
- Genc DB, Canpolat C, Berrak SG. (2011). Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma. Support Care Cancer 20:385–93
- Goellner EM, Grimme B, Brown AR, et al. (2011). Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res 71:2308–17
- Herms JW, von Loewenich FD, Behnke J, et al. (1999). c-Myc oncogene family expression in glioblastoma and survival. Surg Neurol 51:536–42
- Hu YH, Kong SQ, Kong HB, et al. (2012). Targeting c-Myc on cell growth and vascular endothelial growth factor expression in IN500 glioblastoma cells. Chinese Med J 125:2025–31
- Jain RK, di Tomaso E, Duda DG, et al. (2007). Angiogenesis in brain tumours. Nat Rev Neurosci 8:610–22
- Jensen NA, Pedersen KM, Lihme F, et al. (2003). Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas. J Biol Chem 278:8300–8
- Lefranc F, Sadeghi N, Camby I, et al. (2006). Present and potential future issues in glioblastoma treatment. Expert Rev Anticancer Ther 6:719–32
- Li Y, Pei Y, Zhang X, et al. (2001). PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Control Release 71:203–11
- Lu W, Wan J, She Z, Jiang X. (2007). Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release 118:38–53
- Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target specific nanoparticles: Theory to particle. Pharmacol Rev 53:283–318
- Ong BY, Ranganath SH, Lee LY, et al. (2009). Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Biomaterials 30:3189–96
- Orian JM, Vasilopoulos K, Yoshida S, et al. (1992). Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer 66:106–12
- Prabha S, Labhasetwar V. (2004). Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm Res 21:354–64
- Wang J, Wang H, Li Z, et al. (2008). c-Myc is required for maintenance of glioma cancer stem cells. PLoS One 3:e3769
- Zambaux MF, Bonneaux F, Gref R, et al. (2001). Protein C-loaded monomethoxypoly(ethylene oxide)-poly(lactic acid) nanoparticles. Int J Pharm 212:1–9